Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12613000853741
ACTRN12613000853741
Completed
Phase 3

Treatment of Iron Deficiency Anaemia of Late pregnancy with a single intravenous iron versus oral iron sulphate: A Prospective Randomized Controlled Study (TIDAL)

aunceston General Hospital0 sites156 target enrollmentAugust 2, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPregnancy anaemiaPublic Health - Health service researchBlood - AnaemiaReproductive Health and Childbirth - Antenatal care

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pregnancy anaemia
Sponsor
aunceston General Hospital
Enrollment
156
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 2, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
aunceston General Hospital

Eligibility Criteria

Inclusion Criteria

  • •Pregnant women who are 18 years old and above and found to have Hb less than 120 and greater than 85 g/L with ferritin level less than 100mcg/L.

Exclusion Criteria

  • •Megaloblastic anaemia
  • •Myelodysplasia
  • •Aplastic Anaemia
  • •Bone marrow diseases
  • •First trimester of pregnancy
  • •Other disorders as documented by clinician that may be affected by iron therapy.
  • •Documented iron overload status.
  • •Allergic reaction to iron.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Anaemia in pregnancy
CTRI/2024/04/066525Pg Department of Obstetrics and Gynecology ( Ilmul Qabalat wa Amraz e Niswan)
Active, not recruiting
Phase 2
Should we treat iron deficiency anaemia of pregnancy with lactoferrin? A randomised controlled trialLactoferrin Evaluation in Anaemia in PregnancyIron Deficient Anaemia in PregnancyReproductive Health and Childbirth - Fetal medicine and complications of pregnancyReproductive Health and Childbirth - Childbirth and postnatal careDiet and Nutrition - Other diet and nutrition disorders
ACTRN12614000988651niversity of Sydney907
Not yet recruiting
Phase 4
Postpartum IV Iron to Treat Iron Deficiency Anemia Post Delivery TrialHaematological Disorders
PACTR202307876581314ational Institute of Child Health and Development600
Active, not recruiting
Phase 1
TREAT STUDY : TREATMENT OF IRON DEFICIENCY ANAEMIA WITH TARDYFERON. Importance of prolonging iron supplementation in anemic women of childbearing age - TREAT STUDYIron Deficiency Anaemia is a common pathology which concerns less than 5% of women aged 15 to 49 years old in the western countries but can affect up to 30% of the world population, knowing that 9 to 10 anaemic patients live in developing countries. Treating at least 3 months allows to normalize haemoglobin but it is important to carry on the iron treatment in order to fully replenish the iron stores.
EUCTR2006-003378-90-FRPIERRE FABRE MEDICAMENT
Completed
Not Applicable
A clinical trial to compare the rise in hemoglobin and serum ferritin levels after giving either intravenous iron sucrose or oral ferrous ascorbate to anemic pregnant women.Health Condition 1: null- Iron Deficiency Anemia in pregnancy.
CTRI/2010/091/001290Dr Deeba Shafi200